International Clinical Trial: A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Fixed-dose Combination of Dutasteride and Tamsulosin Hydrochloride 0.5/0.4 mg Capsules and Reference Product (DUODART) in Healthy Thai Male Volunteers under Fed Conditions

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (TCTR20260723005) titled 'A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Fixed-dose Combination of Dutasteride and Tamsulosin Hydrochloride 0.5/0.4 mg Capsules and Reference Product (DUODART) in Healthy Thai Male Volunteers under Fed Conditions' on July 23.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: International Bio Service Co., Ltd.

Condition: Bioequivalence study in healthy Thai male volunteers Dutasteride and Tamsulosin Hydrochloride 0.5 mg/0.4 mg Capsules (Dutabit Plus) and Duodart (Dutasteride and tamsulosin hydrochloride) 0.5 mg/0.4 mg hard capsules (Reference)...